Literature DB >> 1838428

Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.

C Bouffioux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1838428

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN： 0300-8886


× No keyword cloud information.
  5 in total

Review 1.  Bladder cancer.

Authors:  H Y Leung; T R Griffiths; D E Neal
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

2.  Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study.

Authors:  V Serretta; G Corselli; B Piazza; D Lio; F Gervasi; S Salerno; M Pavone-Macaluso
Journal:  Urol Res       Date:  1993

3.  Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy.

Authors:  R R Hall; M K Parmar; A B Richards; P H Smith
Journal:  BMJ       Date:  1994-01-22

Review 4.  Evolving immunotherapeutic strategies in bladder and renal cancer.

Authors:  T R L Griffiths; J K Mellon
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

Review 5.  BCG in the treatment of superficial cancer of the bladder: a review.

Authors:  S Friberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1993
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.